See How to Cite and add a link here to your paper once it's online
Cardiovascular outcomes, long-term efficacy and safety In people with T2D and established cardiovascular disease, the international guidelines for T2D recommend the use of GLP-1 RA or sodium glucose co-transporters 2 inhibitors (SGLT-2i) as first-line treatment (independent of HbA1c), based on multiple trials demonstrating their cardio-renal benefits [109]
How BPC-157 Works in the Body Once in your system, either through an injection or an oral supplement, BPC-157 supports the body at a cellular level, promoting healing and improving blood flow to damaged areas
Joint Support and Injury Mitigation The peptide promotes collagen production and maintains cartilage structure, which reduces joint discomfort
However, when inflammation becomes chronic, it can contribute to ongoing pain, reduced mobility, digestive issues, slower recovery, and other health concerns